Oncology Archives | Report Store | Pharma intelligence

show blocks helper

Sort by Default Order
- Default Order
- Name
- Price
- Date
- Popularity

Click to order products descending

Display 15 Products per page

2018 Biomedtracker Datamonitor Healthcare Post-ASH Report

$599.00

The 60th American Society of Hematology (ASH) Annual Meeting and Exposition was held in San Diego, CA from December 1-4, 2018.
January 3, 2019
Find out more
2018 ASH Pulse Survey

$599.00

This 9-question pulse survey of 102 hematologic oncologists practicing throughout the United States and Europe.
January 2, 2019
Find out more
Molecular In Vitro Diagnostic and Screening Tests for Oncology

$4,750.00

The market for molecular in vitro diagnostic and screening tests for oncology totaled approximately $1.0bn in 2017, and is projected to expand at a compound annual growth rate (CAGR) of 13.1% during 2017-22, reaching an estimated $1.9bn.
September 13, 2018
Find out more
PD-1/L1 Immunotherapies: Historical Sales and Market Trend Analysis Report

$7,500.00

Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) has outpaced Merck’s Keytruda (pembrolizumab) primarily
in non-small cell lung cancer (NSCLC) because of its early approval in squamous NSCLC, updated National
Comprehensive Cancer Network (NCCN) guidelines in 2015,
December 22, 2016
Find out more
United Kingdom, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union member state of the U.K.
September 22, 2016
Find out more
U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening

$3,750.00

This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. diagnostic ultrasound, minimally invasive biopsy, and tissue screening products arena.
September 22, 2016
Find out more
France, Disease Incidence and Prevalence

$4,850.00

As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry.

September 22, 2016
Find out more
U.S. Markets for Diagnostic Oncology-Related Magnetic Resonance and Nuclear/Molecular Medicine Imaging

$4,750.00

This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. diagnostic oncology-related MRI and NMMI systems arena.
September 22, 2016
Find out more
U.S. Cancer Statistics Update 2014

$1,950.00

This new report from Medtech Insight includes statistics for new cancer cases, prevalence, and deaths due to the disease in 2014.
September 22, 2016
Find out more
U.S. Markets for Heart Valve Disorder Management Products

$4,750.00

This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.
September 22, 2016
Find out more
The Global Molecular Diagnostics Market

$6,250.00

The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019.
September 22, 2016
Find out more
Global Radiation Therapy Systems Market, March 2016

$3,750.00

This report covers the large, highly competitive, technology driven Global Market for Radiation Therapy Systems—valued at nearly $4.3 billion in 2015.
March 1, 2016
Find out more
Asia-Pacific Disease Incidence and Prevalence

$5,250.00

The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.
January 1, 2016
Find out more
U.S. Surgical Procedure Volumes

$4,750.00

This report presents the most common surgical procedures performed in the United States (U.S.) as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends.
November 1, 2015
Find out more
Asia-Pacific: Surgical Procedure Volumes

$5,250.00

This report examines the healthcare trends in Asia-Pacific countries (Japan, China, South Korea, India, Thailand, Vietnam, Malaysia and Australia), as well as analyzes and forecasts (toward 2019).
September 1, 2015
Find out more

Oncology

Oncology

2018 Biomedtracker Datamonitor Healthcare Post-ASH Report

2018 ASH Pulse Survey

Molecular In Vitro Diagnostic and Screening Tests for Oncology

PD-1/L1 Immunotherapies: Historical Sales and Market Trend Analysis Report

United Kingdom, Surgical Procedure Volumes

U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening

France, Disease Incidence and Prevalence

U.S. Markets for Diagnostic Oncology-Related Magnetic Resonance and Nuclear/Molecular Medicine Imaging

U.S. Cancer Statistics Update 2014

U.S. Markets for Heart Valve Disorder Management Products

The Global Molecular Diagnostics Market

Global Radiation Therapy Systems Market, March 2016

Asia-Pacific Disease Incidence and Prevalence

U.S. Surgical Procedure Volumes

Asia-Pacific: Surgical Procedure Volumes